Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac 0.09% QD in Cataract Surgery
NCT00704418Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromfenac sodium in post-operative inflammation, postoperative pain, sponsored by Bausch + Lomb. Started Jun 2008; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT00704418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00704418.